The seattle heart failure model predicts survival in patients with cardiac resynchronization therapy: A validation study

Journal of Cardiac Failure

Volumn 18, Issue 9, 2012, Pages 682-687

  Clemens, Marcell ^a   Szegedi, Zoltán ^a   Kardos, László ^a   Nagy Baló, Edina ^a   Sándorfi, Gábor ^a   Édes, István ^a   Csanádi, Zoltán ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

cardiac resynchronization therapy; heart failure; mortality; Seattle Heart Failure Model

Indexed keywords

ACCURACY; ADULT; AGED; ARTICLE; CALCULATION; CALIBRATION; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; MORTALITY; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SEATTLE HEART FAILURE MODEL; SURVIVAL; VALIDATION STUDY;

ANTIHYPERTENSIVE AGENTS; CARDIAC RESYNCHRONIZATION THERAPY; DIURETICS; FEMALE; HEALTH STATUS INDICATORS; HEART FAILURE; HUMANS; HUNGARY; MALE; MIDDLE AGED; MODELS, THEORETICAL; PROSPECTIVE STUDIES; REGISTRIES; RISK ASSESSMENT; ROC CURVE;

EID: 84865746458     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2012.07.001     Document Type: Article

References (22)

1. T. Thom, N. Haase, W. Rosamond, V.J. Howard, J. Rumsfeld, and T. Manolio Heart disease and stroke statistics - 2006 update: a report from the American Heart Association Statistics Comittee and stroke statistics subcomittee Circulation 113 2006 e85 e151
2. V.L. Roger, M.A. Weston, M.M. Redfield, J.P. Hellermann-Homan, J. Killian, and B.P. Qawn Trends in heart failure incidence and survival in a community-based population JAMA 292 2004 344 350
3. K.D. Aaronson, J.S. Schwartz, T.M. Chen, K.L. Wong, J.E. Goin, and D.M. Mancini Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation Circulation 95 1997 2660 2667
4. E.A. Rose, A.J. Moskowitz, M. Packer, J.A. Sollano, D.L. Williams, and A.R. Tierney The REMATCH trial: rationale, design, and end points. Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure Ann Thorac Surg 67 1999 723 730
5. L.H. Lund, K.D. Aaronson, and D.M. Mancini Predicting survival in patients with severe heart failure on beta-blocker therapy Am J Cardiol 92 2003 1350 1354
6. T.M. Koelling, S. Joseph, and K.D. Aaronson Heart failure survival score continues to predict clinical outcomes in patients with heart failure receiving beta-blocker J Heart Lung Transplant 23 2004 1414 1422
7. W.C. Levy, D. Mozaffarian, D.T. Linker, S.C. Sutradhar, S.D. Anker, and A.B. Cropp The Seattle Heart Failure Model: prediction of survival in heart failure Circulation 113 2006 1424 1433
8. A.P. Kalogeropoulos, V.V. Georgiopoulou, G. Giamouzis, A.L. Smith, S.A. Agha, and S. Waheed Utility of the Seattle Heart Failure Model in patients with advanced heart failure J Am Coll Cardiol 53 2009 334 342
9. H.T. May, B.D. Horne, W.C. Levy, A.G. Kfoury, K.D. Rasmusson, and D.T. Linker Validation of the Seattle Heart Failure Model in a community-based heart failure population and enhancement by adding B-type natriuretic peptide Am J Cardiol 100 2007 697 700
10. A.L. Nutter, T. Tanawuttiwat, and M.A. Silver Evaluation of 6 prognostic models to calculate mortality rates in elderly heart failure patients with a fatal heart failure admission Congest Heart Fail 16 2010 196 201
11. D.L. Dries, D.V. Exner, M.J. Domanski, B. Greenberg, and L.W. Stevenson The prognostic implications of renal insufficincy in asymptomatic and symptomatic patients with left ventricular systolic dysfunction J Am Coll Cardiol 35 2000 681 689
12. H.L. Hillege, D. Nitsch, M.A. Pfeffer, K. Swedberg, J.J. McMurray, S. Yusuf Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Investigators Renal function as a predictor of outcome in a broad spectrum of patients with heart failure Circulation 113 2006 671 678
13. G. Lin, B.J. Gersh, E.L. Greene, M.M. Redfield, D.L. Hayes, and P.A. Brady Renal function and mortality following cardiac resynchronization therapy Eur Heart J 32 2011 184 190
14. J. Rickard, E.Z. Gorodeski, B. Baranowski, D. Sraow, R. Grimm, and H. Tang Pre-implant left ventricular dilation is an important predictor of response in patients undergoing cardiac resynchronization therapy J Am Coll Cardiol 55 2010 A4.E32
15. A. Chen-Tournoux, V. Nandigam, F. Tournoux, J. Solis-Martin, D. McCarty, and M. Orencole Severe left ventricular dilation is associated with lack of long-term clinical response to cardiac resynchronization therapy Circulation 116 2007 II-603
16. F.M. Merchant, E.K. Heist, D. McCarty, P. Kumar, S. Das, and D. Blendea Impact of segmental left ventricle lead position on cardiac resynchronization therapy outcomes Heart Rhythm 7 2010 639 644
17. J.M. Morgan, and V. Delgado Lead positioning for cardiac resynchronization therapy: techniques and priorities Europace 11 2009 22 28
18. D.T. Martin, S. McNitt, R.W. Nesto, M.K. Rutter, and A.J. Moss Cardiac resynchronization therapy reduces the risk of cardiac events in patients with diabetes enrolled in the Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy (MADIT-CRT) Circ Heart Fail 4 2011 332 338
19. D. Mozaffarian, S.D. Anker, I. Anand, D.T. Linker, L.M.D. Sullivan, and J.G.F. Cleland Prediction of mode of death in heart failure: the Seattle Heart Failure Model Circulation 116 2007 392 398
20. N. Bogale, S. Priori, A. Gitt, M. Alings, C. Linde, K. Dickstein on behalf of the Scientific Committee, National Coordinators, and the Investigators The European cardiac resynchronization therapy survey: patient selection and implantation practice vary according to centre volume Europace 13 2011 1445 1453
21. K. Dickstein, P.E. Vardas, A. Auricchio, J.-C. Daubert, C. Linde, and J. McMurray 2010 focused update of ESC guidelines on device therapy in heart failure Eur Heart J 31 2010 2677 2687
22. G. Giamouzis, A.P. Kalogeropoulos, V.G. Vasiliki, S.A. Agha, M.A. Rashad, and S.R. Laskar Incremental value of renal function in risk prediction with the Seattle Heart Failure Model Am Heart J 157 2009 299 305